SOX2的全癌症分析2:预后影响和作为免疫检查点调节的治疗点的潜力
Shoukai Yu1, Lingmei Qian1, Liling Xu1
1Hongqiao International Institute of Medicine, Shanghai Tongren Hospital and Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Heliyon
|February 13, 2025
概括
SOX2基因的改变影响了30多种癌症类型,影响了预后和免疫反应. 向SOX2可能会提高癌症免疫疗法的有效性,显示其作为治疗点的潜力.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
背景情况:
- SOX2基因在胚胎发育和干细胞维护中起着至关重要的作用.
- 异常的SOX2表达与各种人类癌症有关,但它在各种瘤类型中的全面作用仍然不完全理解.
研究的目的:
- 研究SOX2的遗传,转录和表观遗传变化,涉及30多种癌症类型的广泛范围.
- 确定SOX2表达在不同癌症中的预后意义.
- 探索SOX2表达和免疫检查点抑制剂 (ICI) 反应之间的关系.
主要方法:
- 对SOX2遗传变异,基因表达水平 (转录组学) 和表观遗传修饰的分析.
- SOX2表达与患者生存数据 (预后) 的相关性.
- 评估SOX2表达与免疫检查点基因表达和ICI响应之间的关联.
主要成果:
- 在结直肠,食道,胃和丸癌症中,SOX2表达显著下调,但在宫癌,质母细胞瘤和肺癌中上调.
- 低SOX2表达与膀,肝脏,脏和肉瘤癌的更好的预后相关,而高SOX2表达与肺部,质母细胞瘤和质瘤的预后不佳有关.
- 具有高SOX2表达的瘤对免疫检查点抑制剂的反应增加,尽管免疫检查点表达通常更高.
结论:
- SOX2是癌症预后和多种瘤类型的免疫透的一个重要因素.
- SOX2表达与免疫相关的基因密切相关,并具有作为预后生物标志物和治疗点的潜力.
- 向SOX2可能通过调节免疫检查点来提高癌症免疫治疗的疗效.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Pleiotropy
39.5K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
39.5K


